705
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
adalimumab (HUMIRA®)
The primary objective of the study is to evaluate the safety and tolerability of adalimumab (HUMIRA®) treatment, administered both in monotherapy and combined therapy, in rheumatoid arthritis (RA) patients under usual practice conditions.
Site Reference ID/Investigator# 29706, Cadiz
Site Reference ID/Investigator# 29061, Algeciras
Site Reference ID/Investigator# 29709, Jerez de la Frontera
Site Reference ID/Investigator# 29713, Córdoba
Site Reference ID/Investigator# 29714, A Coruña
Site Reference ID/Investigator# 28607, Ferrol
Site Reference ID/Investigator# 29715, Santiago de Compostela
Site Reference ID/Investigator# 5338, Girona
Site Reference ID/Investigator# 29701, Granada
Site Reference ID/Investigator# 29705, Huelva
Site Reference ID/Investigator# 29708, Jaén
Site Reference ID/Investigator# 29716, Lugo
Site Reference ID/Investigator# 29700, Málaga
Site Reference ID/Investigator# 29065, Cartagena
Site Reference ID/Investigator# 29717, Pamplona
Site Reference ID/Investigator# 29703, El Palmar
Site Reference ID/Investigator# 29051, Ourense
Site Reference ID/Investigator# 29702, Vigo/Pontevedra
Site Reference ID/Investigator# 29697, Vigo
Site Reference ID/Investigator# 29059, Vigo
Site Reference ID/Investigator# 30823, Seville
Site Reference ID/Investigator# 29068, Seville
Site Reference ID/Investigator# 29064, Tarragona
Site Reference ID/Investigator# 29704, Reus
Site Reference ID/Investigator# 29058, Valls
Site Reference ID/Investigator# 29710, Almería
Site Reference ID/Investigator# 29719, Barcelona
Site Reference ID/Investigator# 29054, Barcelona
Site Reference ID/Investigator# 29698, Barcelona
Site Reference ID/Investigator# 29063, Barcelona
Site Reference ID/Investigator# 29718, Barcelona
Site Reference ID/Investigator# 29720, Barcelona
Site Reference ID/Investigator# 29052, Calella
Site Reference ID/Investigator# 29050, Ibiza Town
Site Reference ID/Investigator# 29711, L'Hospitalet de Llobregat
Site Reference ID/Investigator# 29038, Manacor
Site Reference ID/Investigator# 29712, Mataro, Barcelona
Site Reference ID/Investigator# 29699, Palma de Mallorca
Site Reference ID/Investigator# 29055, Vic
Site Reference ID/Investigator# 29053, Viladecans
Lead Sponsor
Abbott
INDUSTRY